Anti-Human EGR4 Antibody
Anti-Human EGR4 Antibody with collaborator-tested evidence for IHC-P. Read more ›
["IHC-P"]
Product Description
EGR4 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Polyclonal; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC-P. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: E. coli-derived Human EGR4 fragment; purification: Protein A & Antigen Affinity; concentration: 1 mg/mL.
Database references: UniProt: Q05215 | NCBI Gene: 1961.
Research Use Only.
Key Facts
| Target | EGR4 |
| Also known as | EGR, PAT, Early growth response protein, AT133, Early growth response protein 4, Nerve growth factor induced clone C, NGFI C, NGFIC, PAT133, EGR4 |
| Concentration | 1 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Epigenetics and Nuclear Signaling |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.